Advanced Medical Solutions Group (LON:AMS) Earns Sector Perform Rating from Royal Bank Of Canada

Advanced Medical Solutions Group (LON:AMS)‘s stock had its “sector perform” rating reiterated by stock analysts at Royal Bank Of Canada in a research report issued to clients and investors on Thursday,London Stock Exchange reports. They presently have a GBX 260 target price on the stock. Royal Bank Of Canada’s target price points to a potential upside of 28.08% from the company’s current price.

Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 300 price objective on shares of Advanced Medical Solutions Group in a research report on Wednesday, March 18th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of GBX 270.25.

Advanced Medical Solutions Group Stock Performance

Shares of Advanced Medical Solutions Group stock opened at GBX 203 on Thursday. The stock’s fifty day moving average is GBX 204.95 and its two-hundred day moving average is GBX 213.13. The company has a market capitalization of £439.30 million, a PE ratio of 44.91, a price-to-earnings-growth ratio of 5.00 and a beta of 0.63. The company has a quick ratio of 4.58, a current ratio of 2.79 and a debt-to-equity ratio of 31.50. Advanced Medical Solutions Group has a 52 week low of GBX 168.40 and a 52 week high of GBX 248.50.

Advanced Medical Solutions Group (LON:AMS) last announced its quarterly earnings data on Wednesday, March 18th. The company reported GBX 11.98 EPS for the quarter. Advanced Medical Solutions Group had a return on equity of 3.87% and a net margin of 4.35%. As a group, analysts expect that Advanced Medical Solutions Group will post 9.8159509 earnings per share for the current year.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.